+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Animal Drug Compounding Market Size, Share & Trends Analysis Report By Product, By Animal Type, By Route Of Administration, By Dosage Form, By Region, And Segment Forecasts, 2025 - 2030- Product Image
Animal Drug Compounding Market Size, Share & Trends Analysis Report By Product, By Animal Type, By Route Of Administration, By Dosage Form, By Region, And Segment Forecasts, 2025 - 2030- Product Image
New

Animal Drug Compounding Market Size, Share & Trends Analysis Report By Product, By Animal Type, By Route Of Administration, By Dosage Form, By Region, And Segment Forecasts, 2025 - 2030

  • PDF Icon

    Report

  • 150 Pages
  • December 2024
  • Region: Global
  • Grand View Research
  • ID: 5767757
Description Jump to:

Animal Drug Compounding Market Growth & Trends

The global animal drug compounding market size is anticipated to reach USD 2.45 billion by 2030. The market is projected to grow at a CAGR of 8.29% from 2025 to 2030. The key factors driving the market growth include a rise in pet adoption, huge animal healthcare spending, increased pet owner awareness regarding specialty pharmaceuticals, the high cost of branded veterinary products, pet humanization trends, and an increase in the demand for custom-made, compounded animal medications.

The COVID-19 pandemic had a negative impact on the market for animal drug compounding in 2020, just like on several other global industries. The most significant effects of COVID-19 on the veterinary healthcare system are supply chain disruptions, a drop in sales, a slowdown in demand, and operational challenges brought on by shifting regulations and policies. Manufacturing firms, veterinary pharmacies, and animal care service providers were severely impacted as many areas entered state-wide lockdowns and imposed restrictions on the movement of people and goods. For instance, according to the American veterinary medical association, in April 2020, approximately 60% of veterinary practices were canceled or delayed due to the outbreak of coronavirus and in July 2020, the number of veterinary practices declined to about 30%. Thus, the impact of COVID-19 has hampered market growth.

Compounding veterinary drugs fills the gaps left by less readily available licensed drugs for veterinary treatment and other veterinary medication alternatives. Compounded medications are a better choice for treating a wide range of animal diseases when FDA-approved drugs are difficult to find for certain medical conditions. For instance, chewable tablets are commercially approved products in specific dosage forms and are suggested for use in certain animal species yet are unacceptable for use in animals such as cats or exotic pets. Similarly, widely available medications have an unpleasant taste for some animals limiting the administering rate. In this case, animal drug compounding is preferred, particularly for difficult-to-administer medications.

During the pandemic, pet adoption considerably increased, leading to an increased animal healthcare infrastructure and driving the market for compounded medications for animals. According to a report published by the American Society for the Prevention of Cruelty to Animals (ASPCA) in May 2021, one in every five families had adopted a cat or dog since the COVID-19 pandemic began. The increased focus on pet health brought on by adoptions during the pandemic is expected to drive the expansion of the animal drug compounding market over the coming years.

Similarly, the global animal drug compounding market is expected to expand due to market players focusing on programs and initiatives concerning veterinary health. For instance, in June 2021, Covetrus acquired VCP, a platform for administering veterinary wellness plans that serves about 1,000 practices and presently benefits over 350,000 pets through wellness plans that are enabled by VCP. Covetrus will make use of the infrastructure and technology platform provided by VCP to offer new methods for vets to develop closer bonds with their pet owners and produce better results in terms of both business and healthcare.

Animal Drug Compounding Market Report Highlights

  • Based on animal type, the companion animals segment accounted for the largest revenue share in 2024. This can be attributed to the increasing adoption of pet animals, the rise in animal expenditure, and the increasing demand for compounding medication for pet animals.
  • Based on products, the CNS agents segment dominated with a market share of around 33% in 2024, as CNS agents are the most frequently prescribed medication for treating neurological conditions such as changes in behavior, blindness, seizures, epilepsy, etc., in pets. Hormones & Substitutes is the fastest-growing segment with a rate of over 9.0% since it is better and more potent for hormonal imbalance treatment in animals.
  • Among routes of administration, the oral segment held the largest market share of more than 53 % in 2024, as oral formulations are the preferred, easy, and more acceptable route of drug administration. Whereas, topical is the fastest-growing segment among the routes of administration, with a growth rate of over 9.0% during the forecast period.
  • Based on dosage form, the suspensions segment accounted for the largest revenue share of about 49% in 2024, as suspensions were the most dispensed compounded dosage form for animals. The Solutions segment is estimated to register the highest CAGR of over 8% in the coming years owing to the several benefits of the solution compared to another solid dosage form. Solutions are usually more GI mucosa-friendly than solid dosage forms as they are more quickly absorbed. In addition, unlike suspensions, phase separation during storing is not an issue with solutions. Thus, solutions are expected to gain popularity during the forecast period.
  • North America attributed the largest share of about 40% of the market by region in 2024, owing to an increase in pet ownership together with rising animal health expenditure and high demand for animal drug compounding. While Asia pacific is expected to grow at the fastest CAGR of about 10.0% due to an increase in pet humanization, growing animal healthcare expenditure, and the availability of low-cost animal compounding medications.

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players worldwide.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Animal Type
1.2.3. Route of Administration
1.2.4. Dosage Form
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Animal Drug Compounding Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTLE Analysis
Chapter 4. Animal Drug Compounding Market: Product Business Analysis
4.1. Product Market Share, 2024 & 2030
4.2. Product Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Anti-infective Agents
4.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Anti-inflammatory Agents
4.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.6. Hormones & Substitutes
4.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.7. CNS Agents
4.7.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.8. Other Products
4.8.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Animal Drug Compounding Market: Animal Type Business Analysis
5.1. Animal Type Market Share, 2024 & 2030
5.2. Animal Type Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Animal Type, 2018 to 2030 (USD Million)
5.4. Companion Animal
5.4.1. Dogs
5.4.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
5.4.2. Cats
5.4.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
5.4.3. Horses
5.4.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
5.4.4. Others
5.4.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Livestock Animal
5.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Animal Drug Compounding Market: Route of Administration Business Analysis
6.1. Route of Administration Market Share, 2024 & 2030
6.2. Route of Administration Segment Dashboard
6.3. Market Size & Forecasts and Trend Analysis, by Route of Administration, 2018 to 2030 (USD Million)
6.4. Oral
6.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Injectable
6.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.6. Topical
6.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.7. Other Routes
6.7.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Animal Drug Compounding Market: Dosage Form Business Analysis
7.1. Dosage Form Market Share, 2024 & 2030
7.2. Dosage Form Segment Dashboard
7.3. Market Size & Forecasts and Trend Analysis, by Dosage Form, 2018 to 2030 (USD Million)
7.4. Suspensions
7.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
7.5. Solutions
7.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
7.6. Capsules
7.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 8. Animal Drug Compounding Market: Regional Estimates & Trend Analysis by Product, Animal Type, Route of Administration, and Dosage Form
8.1. Regional Market Share Analysis, 2024 & 2030
8.2. Regional Market Dashboard
8.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
8.4. North America
8.4.1. North America animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
8.4.2. U.S.
8.4.2.1. Key country dynamics
8.4.2.2. U.S. animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
8.4.3. Canada
8.4.3.1. Key country dynamics
8.4.3.2. Canada animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
8.4.4. Mexico
8.4.4.1. Key country dynamics
8.4.4.2. Mexico animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
8.5. Europe
8.5.1. Europe animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
8.5.2. UK
8.5.2.1. Key country dynamics
8.5.2.2. UK animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
8.5.3. Germany
8.5.3.1. Key country dynamics
8.5.3.2. Germany animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
8.5.4. France
8.5.4.1. Key country dynamics
8.5.4.2. France animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
8.5.5. Italy
8.5.5.1. Key country dynamics
8.5.5.2. Italy animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
8.5.6. Spain
8.5.6.1. Key country dynamics
8.5.6.2. Spain animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
8.5.7. Norway
8.5.7.1. Key country dynamics
8.5.7.2. Norway animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
8.5.8. Denmark
8.5.8.1. Key country dynamics
8.5.8.2. Denmark animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
8.5.9. Sweden
8.5.9.1. Key country dynamics
8.5.9.2. Sweden animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
8.6. Asia Pacific
8.6.1. Asia Pacific animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
8.6.2. Japan
8.6.2.1. Key country dynamics
8.6.2.2. Japan animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
8.6.3. China
8.6.3.1. Key country dynamics
8.6.3.2. China animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
8.6.4. India
8.6.4.1. Key country dynamics
8.6.4.2. India animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
8.6.5. South Korea
8.6.5.1. Key country dynamics
8.6.5.2. South Korea animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
8.6.6. Australia
8.6.6.1. Key country dynamics
8.6.6.2. Australia animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
8.7. Latin America
8.7.1. Latin America animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
8.7.2. Brazil
8.7.2.1. Key country dynamics
8.7.2.2. Brazil animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
8.7.3. Argentina
8.7.3.1. Key country dynamics
8.7.3.2. Argentina animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
8.8. MEA
8.8.1. MEA animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
8.8.2. South Africa
8.8.2.1. Key country dynamics
8.8.2.2. South Africa animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
8.8.3. Saudi Arabia
8.8.3.1. Key country dynamics
8.8.3.2. Saudi Arabia animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
8.8.4. UAE
8.8.4.1. Key country dynamics
8.8.4.2. UAE animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
8.8.5. Kuwait
8.8.5.1. Key country dynamics
8.8.5.2. Kuwait animal drug compounding market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Participant Overview
9.2. Company Market Position Analysis
9.3. Company Categorization
9.4. Strategy Mapping
9.5. Company Profiles/Listing
9.5.1. WEDGEWOOD PHARMACY
9.5.1.1. Overview
9.5.1.2. Financial performance
9.5.1.3. Product benchmarking
9.5.1.4. Strategic initiatives
9.5.2. Vimian
9.5.2.1. Overview
9.5.2.2. Financial performance
9.5.2.3. Product benchmarking
9.5.2.4. Strategic initiatives
9.5.3. Pharmaca
9.5.3.1. Overview
9.5.3.2. Financial performance
9.5.3.3. Product benchmarking
9.5.3.4. Strategic initiatives
9.5.4. Akina Animal Health
9.5.4.1. Overview
9.5.4.2. Financial performance
9.5.4.3. Product benchmarking
9.5.4.4. Strategic initiatives
9.5.5. Triangle Compounding
9.5.5.1. Overview
9.5.5.2. Financial performance
9.5.5.3. Product benchmarking
9.5.5.4. Strategic initiatives
9.5.6. Davis Islands Pharmacy and Compounding Lab
9.5.6.1. Overview
9.5.6.2. Financial performance
9.5.6.3. Product benchmarking
9.5.6.4. Strategic initiatives
9.5.7. Custom Med Compounding Pharmacy
9.5.7.1. Overview
9.5.7.2. Financial performance
9.5.7.3. Product benchmarking
9.5.7.4. Strategic initiatives
9.5.8. Central Compounding Center South
9.5.8.1. Overview
9.5.8.2. Financial performance
9.5.8.3. Product benchmarking
9.5.8.4. Strategic initiatives
9.5.9. Wellness Pharmacy of Cary
9.5.9.1. Overview
9.5.9.2. Financial performance
9.5.9.3. Product benchmarking
9.5.9.4. Strategic initiatives
9.5.10. Miller's Pharmacy
9.5.10.1. Overview
9.5.10.2. Financial performance
9.5.10.3. Product benchmarking
9.5.10.4. Strategic initiatives
Chapter 10. Key Takeaways
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
Table 4 Global Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
Table 5 Global Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 6 Global Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 7 Global Animal Drug Compounding Market, By Region, 2018 - 2030 (USD Million)
Table 8 North America Animal Drug Compounding Market, By Country, 2018 - 2030 (USD Million)
Table 9 North America Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
Table 10 North America Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
Table 11 North America Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 12 North America Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 13 U.S. Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
Table 14 U.S. Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
Table 15 U.S. Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 16 U.S. Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 17 Canada Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
Table 18 Canada Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
Table 19 Canada Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 20 Canada Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 21 Mexico Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
Table 22 Mexico Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
Table 23 Mexico Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 24 Mexico Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 25 Europe Animal Drug Compounding Market, By Country, 2018 - 2030 (USD Million)
Table 26 Europe Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
Table 27 Europe Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
Table 28 Europe Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 29 Europe Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 30 Germany Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
Table 31 Germany Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
Table 32 Germany Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 33 Germany Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 34 UK Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
Table 35 UK Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
Table 36 UK Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 37 UK Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 38 France Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
Table 39 France Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
Table 40 France Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 41 France Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 42 Italy Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
Table 43 Italy Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
Table 44 Italy Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 45 Italy Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 46 Spain Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
Table 47 Spain Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
Table 48 Spain Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 49 Spain Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 50 Denmark Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
Table 51 Denmark Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
Table 52 Denmark Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 53 Denmark Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 54 Sweden Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
Table 55 Sweden Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
Table 56 Sweden Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 57 Sweden Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 58 Norway Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
Table 59 Norway Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
Table 60 Norway Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 61 Norway Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 62 Asia Pacific Animal Drug Compounding Market, By Country, 2018 - 2030 (USD Million)
Table 63 Asia Pacific Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
Table 64 Asia Pacific Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
Table 65 Asia Pacific Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 66 Asia Pacific Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 67 China Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
Table 68 China Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
Table 69 China Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 70 China Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 71 Japan Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
Table 72 Japan Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
Table 73 Japan Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 74 Japan Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 75 India Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
Table 76 India Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
Table 77 India Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 78 India Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 79 South Korea Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
Table 80 South Korea Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
Table 81 South Korea Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 82 South Korea Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 83 Australia Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
Table 84 Australia Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
Table 85 Australia Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 86 Australia Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 87 Latin America Animal Drug Compounding Market, By Country, 2018 - 2030 (USD Million)
Table 88 Latin America Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
Table 89 Latin America Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
Table 90 Latin America Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 91 Latin America Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 92 Brazil Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
Table 93 Brazil Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
Table 94 Brazil Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 95 Brazil Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 96 Argentina Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
Table 97 Argentina Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
Table 98 Argentina Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 99 Argentina Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 100 Middle East & Africa Animal Drug Compounding Market, By Country, 2018 - 2030 (USD Million)
Table 101 Middle East & Africa Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
Table 102 Middle East & Africa Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
Table 103 Middle East & Africa Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 104 Middle East & Africa Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 105 South Africa Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
Table 106 South Africa Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
Table 107 South Africa Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 108 South Africa Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 109 Saudi Arabia Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
Table 110 Saudi Arabia Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
Table 111 Saudi Arabia Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 112 Saudi Arabia Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 113 UAE Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
Table 114 UAE Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
Table 115 UAE Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 116 UAE Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 117 Kuwait Animal Drug Compounding Market, By Animal Type, 2018 - 2030 (USD Million)
Table 118 Kuwait Animal Drug Compounding Market, By Product, 2018 - 2030 (USD Million)
Table 119 Kuwait Animal Drug Compounding Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 120 Kuwait Animal Drug Compounding Market, By Dosage Form, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Information Procurement
Fig. 3 Primary Research Pattern
Fig. 4 Market Research Approaches
Fig. 5 Value Chain-Based Sizing & Forecasting
Fig. 6 Market Formulation & Validation
Fig. 7 Animal Drug Compounding Market, Market Segmentation
Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 12 Porter’s Five Forces Analysis
Fig. 13 Regional Marketplace: Key Takeaways
Fig. 14 Global Animal Drug Compounding Market, for Product, 2018 - 2030 (USD Million)
Fig. 15 Global Animal Drug Compounding Market, for Anti-infective Agents, 2018 - 2030 (USD Million)
Fig. 16 Global Animal Drug Compounding Market, for Anti-inflammatory Agents, 2018 - 2030 (USD Million)
Fig. 17 Global Animal Drug Compounding Market, for Hormones & Substitutes, 2018 - 2030 (USD Million)
Fig. 18 Global Animal Drug Compounding Market, for CNS Agents, 2018 - 2030 (USD Million)
Fig. 19 Global Animal Drug Compounding Market, for Other Products, 2018 - 2030 (USD Million)
Fig. 20 Global Animal Drug Compounding Market, for Animal Type, 2018 - 2030 (USD Million)
Fig. 21 Global Animal Drug Compounding Market, for Companion Animal, 2018 - 2030 (USD Million)
Fig. 22 Global Animal Drug Compounding Market, for Dogs, 2018 - 2030 (USD Million)
Fig. 23 Global Animal Drug Compounding Market, for Cats, 2018 - 2030 (USD Million)
Fig. 24 Global Animal Drug Compounding Market, for Others, 2018 - 2030 (USD Million)
Fig. 25 Global Animal Drug Compounding Market, for Livestock Animal, 2018 - 2030 (USD Million)
Fig. 26 Global Animal Drug Compounding Market, for Route of Administration, 2018 - 2030 (USD Million)
Fig. 27 Global Animal Drug Compounding Market, for Oral, 2018 - 2030 (USD Million)
Fig. 28 Global Animal Drug Compounding Market, for Injectable, 2018 - 2030 (USD Million)
Fig. 29 Global Animal Drug Compounding Market, for Topical, 2018 - 2030 (USD Million)
Fig. 30 Global Animal Drug Compounding Market, for Other Routes, 2018 - 2030 (USD Million)
Fig. 31 Global Animal Drug Compounding Market, for Dosage Form, 2018 - 2030 (USD Million)
Fig. 32 Global Animal Drug Compounding Market, for Suspensions, 2018 - 2030 (USD Million)
Fig. 33 Global Animal Drug Compounding Market, for Solutions, 2018 - 2030 (USD Million)
Fig. 34 Global Animal Drug Compounding Market, for Capsules, 2018 - 2030 (USD Million)
Fig. 35 Regional Outlook, 2024 & 2030
Fig. 36 North America Animal Drug Compounding Market, 2018 - 2030 (USD Million)
Fig. 37 U.S. Animal Drug Compounding Market, 2018 - 2030 (USD Million)
Fig. 38 Canada Animal Drug Compounding Market, 2018 - 2030 (USD Million)
Fig. 39 Mexico Animal Drug Compounding Market, 2018 - 2030 (USD Million)
Fig. 40 Europe Animal Drug Compounding Market, 2018 - 2030 (USD Million)
Fig. 41 Germany Animal Drug Compounding Market, 2018 - 2030 (USD Million)
Fig. 42 UK Animal Drug Compounding Market, 2018 - 2030 (USD Million)
Fig. 43 France Animal Drug Compounding Market, 2018 - 2030 (USD Million)
Fig. 44 Italy Animal Drug Compounding Market, 2018 - 2030 (USD Million)
Fig. 45 Spain Animal Drug Compounding Market, 2018 - 2030 (USD Million)
Fig. 46 Denmark Animal Drug Compounding Market, 2018 - 2030 (USD Million)
Fig. 47 Sweden Animal Drug Compounding Market, 2018 - 2030 (USD Million)
Fig. 48 Norway Animal Drug Compounding Market, 2018 - 2030 (USD Million)
Fig. 49 Asia Pacific Animal Drug Compounding Market, 2018 - 2030 (USD Million)
Fig. 50 Japan Animal Drug Compounding Market, 2018 - 2030 (USD Million)
Fig. 51 China Animal Drug Compounding Market, 2018 - 2030 (USD Million)
Fig. 52 India Animal Drug Compounding Market, 2018 - 2030 (USD Million)
Fig. 53 Australia Animal Drug Compounding Market, 2018 - 2030 (USD Million)
Fig. 54 South Korea Animal Drug Compounding Market, 2018 - 2030 (USD Million)
Fig. 55 Latin America Animal Drug Compounding Market, 2018 - 2030 (USD Million)
Fig. 56 Brazil Animal Drug Compounding Market, 2018 - 2030 (USD Million)
Fig. 57 Argentina Animal Drug Compounding Market, 2018 - 2030 (USD Million)
Fig. 58 Middle East and Africa Animal Drug Compounding Market, 2018 - 2030 (USD Million)
Fig. 59 South Africa Animal Drug Compounding Market, 2018 - 2030 (USD Million)
Fig. 60 Saudi Arabia Animal Drug Compounding Market, 2018 - 2030 (USD Million)
Fig. 61 UAE Animal Drug Compounding Market, 2018 - 2030 (USD Million)
Fig. 62 Kuwait Animal Drug Compounding Market, 2018 - 2030 (USD Million)
Fig. 63 Company categorization
Fig. 64 Company market position analysis
Fig. 65 Strategic framework

Companies Mentioned

  • WEDGEWOOD PHARMACY
  • Vimian
  • Pharmaca.
  • Akina Animal Health
  • Triangle Compounding.
  • Davis Islands Pharmacy and Compounding Lab
  • Custom Med Compounding Pharmacy
  • Central Compounding Center South
  • Wellness Pharmacy of Cary
  • Miller's Pharmacy

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages150
PublishedDecember 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 1.52 billion
Forecasted Market Value ( USD ) by 2030 $ 2.45 billion
Compound Annual Growth Rate8.2%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Animal Drug Compounding Market by Product, Form, Administration, Animal, End-User - Global Forecast 2025-2030 - Product Image

Animal Drug Compounding Market by Product, Form, Administration, Animal, End-User - Global Forecast 2025-2030

  • Report
  • 187 Pages
  • Global
From
Animal Drug Compounding Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2024-2032 - Product Image

Animal Drug Compounding Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2024-2032

  • Report
  • 115 Pages
  • Global
From
U.S. Animal Drug Compounding Market - Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Country: (U.S.) - Product Image

U.S. Animal Drug Compounding Market - Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Country: (U.S.)

  • Report
  • 79 Pages
  • United States
From
Drug Compounding for Veterinary Professionals. Edition No. 1 - Product Image

Drug Compounding for Veterinary Professionals. Edition No. 1

  • Book
  • 176 Pages
Therapeutics, An Issue of Veterinary Clinics of North America: Exotic Animal Practice. The Clinics: Veterinary Medicine Volume 21-2 - Product Image

Therapeutics, An Issue of Veterinary Clinics of North America: Exotic Animal Practice. The Clinics: Veterinary Medicine Volume 21-2

  • Book
  • North America
Copyright © 2002-2025 Research and Markets. All Rights Reserved.